News Focus
News Focus
icon url

jaspirr

02/24/20 10:43 AM

#247713 RE: VuBru #247711

Do we have an estimate of when the EVAPORATE trial will be completed? I've been searching all over and I can't find much. It has been more than a year since they bothered to update the trial on www.clinicaltrials.gov, where it estimated completion in September 2019.

It is not clear when the 9 month interim look was available. Obviously it was available prior to November 2019. If the interim was available in, for example, May 2019, then our 18 month should be finished right about now.
icon url

ziploc_1

02/24/20 10:56 AM

#247716 RE: VuBru #247711

Vu..."stent struts may contribute to neointimal formation and restenosis. In this context, the question is raised whether this potential atherosclerotic tissue shift after stent placement may also be responsible for neoatherosclerosis of stent struts contributing to neointimal formation and restenosis. In this context, the question is raised whether this potential atherosclerotic tissue shift after stent placement may also be responsible for neoatherosclerosis."

Many thousand of patients are walking around with stents, hoping that they will stay open indefinitely...Decrease in atheroma formation is indeed a desirable outcome..as demonstrated in the Evaporate interim analysis and likely to be further demonstrated in the full analysis.
icon url

sharinky

02/24/20 11:11 AM

#247717 RE: VuBru #247711

It is my understanding that the primary did have an effect, it was just not significant due to the short time frame.